Owens & Minor Q3 earnings beat estimates, revenue up 5% YoY

RICHMOND, Va. - Owens & Minor, Inc. (NYSE:OMI ) reported third-quarter earnings that exceeded analyst expectations, with revenue growing 5% year-over-year, driven by solid demand in its Patient Direct and Medical Distribution segments.

OMI shares were up 0.75% following the announcement Monday.

The healthcare solutions company posted adjusted earnings per share of $0.42, beating the analyst consensus of $0.41. Revenue for the quarter came in at $2.72 billion, surpassing estimates of $2.68 billion and representing a 5% increase from the same period last year.

Owens & Minor's Patient Direct segment saw revenue rise 6% to $687 million compared to the third quarter of 2023, fueled by strength in diabetes and sleep supplies. The Products & Healthcare Services (NASDAQ:HCSG ) segment revenue grew 5% to $2.0 billion, driven primarily by strong same-store sales in Medical Distribution.

"Our third quarter results demonstrated our ability to deliver on our commitments both near-term as well as on our strategic initiatives," said Edward A. Pesicka, President & CEO of Owens & Minor.

The company reported a GAAP net loss of $13 million, or -$0.17 per share, for the quarter. Adjusted EBITDA increased 5% year-over-year to $142 million.

Owens & Minor reduced its total debt by $198 million in the third quarter, including full redemption of its 2024 senior notes.

For the full year 2024, the company narrowed its guidance, now expecting adjusted EPS between $1.45 and $1.55, compared to the analyst consensus of $1.59. Revenue is projected to be in the range of $10.6 billion to $10.8 billion.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Source: Investing.com